Human induced pluripotent stem cell for modeling cardiovascular diseases

Area of Science:

• Regenerative Medicine
• Cardiology
• Stem Cell Biology

Background:

• Cardiovascular diseases (CVDs) are a leading global cause of mortality.
• Existing cardiac cell models face limitations in cell derivation and quantity for studying CVDs.
• Induced pluripotent stem cell (iPSC) technology enables the generation of patient-specific pluripotent stem cells.

Purpose of the Study:

• To review the current advancements in utilizing iPSC-derived cardiomyocytes for modeling human cardiovascular diseases.
• To highlight the potential of iPSC-based 'disease in a dish' models for understanding CVD mechanisms.

Main Methods:

• Generation of patient-specific induced pluripotent stem cells (iPSCs) from somatic cells.
• Differentiation of iPSCs into cardiomyocytes.
• Application of iPSC-derived cardiomyocytes in creating disease models.

Main Results:

• iPSCs can be differentiated into various cell types, including cardiomyocytes.
• Patient-specific iPSC-derived cardiomyocytes provide a viable model for studying human CVDs.
• These models overcome limitations of traditional cardiac cell research.

Conclusions:

• iPSC-derived cardiomyocytes represent a significant breakthrough in cardiovascular disease research.
• These models facilitate a deeper understanding of disease mechanisms.
• The review summarizes progress and potential of iPSC-based CVD modeling.